Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback